Michael D. Cameron

11.4k total citations · 2 hit papers
171 papers, 7.5k citations indexed

About

Michael D. Cameron is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Michael D. Cameron has authored 171 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Molecular Biology, 28 papers in Cellular and Molecular Neuroscience and 26 papers in Organic Chemistry. Recurrent topics in Michael D. Cameron's work include Receptor Mechanisms and Signaling (25 papers), Neuropeptides and Animal Physiology (17 papers) and Melanoma and MAPK Pathways (16 papers). Michael D. Cameron is often cited by papers focused on Receptor Mechanisms and Signaling (25 papers), Neuropeptides and Animal Physiology (17 papers) and Melanoma and MAPK Pathways (16 papers). Michael D. Cameron collaborates with scholars based in United States, Brazil and China. Michael D. Cameron's co-authors include Theodore M. Kamenecka, Steven D. Aust, Claudia Ruiz, Derek R. Duckett, Xiaohai Li, Thomas D. Bannister, Laura Bohn, Cullen L. Schmid, Youseung Shin and Yuanjun He and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael D. Cameron

167 papers receiving 7.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists

2012 649 citations Michael D. Cameron, Theodore M. Kamenecka et al. profile →
Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics

2017 372 citations Cullen L. Schmid, Nicole Kennedy et al. Cell profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael D. Cameron	4.0k	1.3k	1.0k	929	892	171	7.5k
Theodore M. Kamenecka	4.0k 1.0×	900 0.7×	2.1k 2.0×	1.0k 1.1×	1.6k 1.8×	148	8.3k
Daniel K. Nomura	9.8k 2.4×	1.2k 0.9×	1.7k 1.6×	1.5k 1.6×	489 0.5×	165	17.5k
Lorenzo Di Cesare Mannelli	3.7k 0.9×	902 0.7×	1.9k 1.8×	1.6k 1.7×	277 0.3×	314	8.7k
Thomas P. Burris	6.4k 1.6×	1.3k 1.0×	3.0k 3.0×	492 0.5×	3.0k 3.3×	190	13.4k
Feng Li	4.9k 1.2×	673 0.5×	2.1k 2.0×	509 0.5×	417 0.5×	335	10.7k
Zhihong Huang	5.6k 1.4×	1.6k 1.2×	2.5k 2.5×	371 0.4×	574 0.6×	135	12.5k
Katia Varani	5.2k 1.3×	2.3k 1.7×	926 0.9×	2.1k 2.2×	336 0.4×	302	11.7k
Thomas S. Scanlan	5.0k 1.2×	1.2k 0.9×	1.2k 1.2×	765 0.8×	734 0.8×	177	11.7k
Pamela Maher	9.5k 2.3×	2.7k 2.1×	2.8k 2.8×	497 0.5×	245 0.3×	229	16.8k
Kenneth Hensley	3.7k 0.9×	1.4k 1.0×	3.2k 3.1×	741 0.8×	257 0.3×	130	9.7k

Countries citing papers authored by Michael D. Cameron

Since Specialization

Citations

This map shows the geographic impact of Michael D. Cameron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Cameron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Cameron more than expected).

Fields of papers citing papers by Michael D. Cameron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Cameron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Cameron. The network helps show where Michael D. Cameron may publish in the future.

Co-authorship network of co-authors of Michael D. Cameron

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Cameron. A scholar is included among the top collaborators of Michael D. Cameron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Cameron. Michael D. Cameron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ling, Lijun, Luisa Mori, Wenbo Yao, et al.. (2025). Combining spironolactone to antiretroviral therapy accelerates HIV decay in humanized mice. Emerging Microbes & Infections. 14(1). 2589549–2589549.

Voren, George, Christie D. Fowler, Qun Lu, et al.. (2024). SR9883 is a novel small-molecule enhancer of α4β2* nicotinic acetylcholine receptor signaling that decreases intravenous nicotine self-administration in rats. Frontiers in Molecular Neuroscience. 17. 1459098–1459098. 2 indexed citations

Gaisin, Arsen, Mario Moisés Álvarez, Terry W. Moore, et al.. (2024). Guardians at the Gate: Optimization of Small Molecule Entry Inhibitors of Ebola and Marburg Viruses. Journal of Medicinal Chemistry. 68(1). 135–155.

Thomas, Michael, Alexander E. Ivliev, Adam Štefek, et al.. (2024). REM-422, a Small Molecule MYB mRNA Degrader, Demonstrates Anti-Leukemic Activity As Monotherapy and in Combination with Standards of Care in Preclinical Models of AML. Blood. 144(Supplement 1). 826–826. 1 indexed citations

Lin, Li, et al.. (2023). Basolateral amygdala corticotropin releasing factor receptor 2 interacts with nonmuscle myosin II to destabilize memory in males. Neurobiology of Learning and Memory. 206. 107865–107865. 3 indexed citations

Primi, Marina Candido, Claudia Ruiz, Thales Kronenberger, et al.. (2023). HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents. European Journal of Medicinal Chemistry. 263. 115935–115935. 4 indexed citations

Cameron, Michael D., Nina Magnolo, Vimal H. Prajapati, et al.. (2023). 425 Effect of upadacitinib on SCORAD intensity items: analysis from the Measure Up 1 and Measure Up 2 studies. British Journal of Dermatology. 188(Supplement_3). 1 indexed citations

Mondal, Santanu, Yongzhi Chen, G.J. Lockbaum, et al.. (2022). Dual Inhibitors of Main Protease (M^Pro) and Cathepsin L as Potent Antivirals against SARS-CoV2. Journal of the American Chemical Society. 144(46). 21035–21045. 31 indexed citations

Radnai, László, M. D. Surman, Erica J. Young, et al.. (2021). Discovery of Selective Inhibitors for In Vitro and In Vivo Interrogation of Skeletal Myosin II. ACS Chemical Biology. 16(11). 2164–2173. 4 indexed citations

10.

Lin, Hua, Kfir Sharabi, Lin Li, et al.. (2021). Structure–Activity Relationship and Biological Investigation of SR18292 (16), a Suppressor of Glucagon-Induced Glucose Production. Journal of Medicinal Chemistry. 64(2). 980–990. 4 indexed citations

11.

Mediouni, Sonia, Joseph Jablonski, Cari F. Kessing, et al.. (2020). Oregano Oil and Its Principal Component, Carvacrol, Inhibit HIV-1 Fusion into Target Cells. Journal of Virology. 94(15). 45 indexed citations

12.

To, Ciric, Jaebong Jang, Ting Chen, et al.. (2019). Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor. Cancer Discovery. 9(7). 926–943. 250 indexed citations

13.

Angelbello, Alicia J., Suzanne G. Rzuczek, Kendra McKee, et al.. (2019). Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model. Proceedings of the National Academy of Sciences. 116(16). 7799–7804. 91 indexed citations

14.

Huang, Xi‐Ping, Tao Che, Thomas J. Mangano, et al.. (2017). Fentanyl-related designer drugs W-18 and W-15 lack appreciable opioid activity in vitro and in vivo. JCI Insight. 2(22). 17 indexed citations

15.

Schmid, Cullen L., Nicole Kennedy, Nicolette C. Ross, et al.. (2017). Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics. Cell. 171(5). 1165–1175.e13. 372 indexed citations breakdown →

16.

Brust, Tarsis F., Jenny Morgenweck, Susy A. Kim, et al.. (2016). Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria. Science Signaling. 9(456). ra117–ra117. 177 indexed citations

17.

Andero, Raül, Shaun P. Brothers, Tanja Jovanović, et al.. (2013). Amygdala-Dependent Fear Is Regulated by Oprl1 in Mice and Humans with PTSD. Science Translational Medicine. 5(188). 188ra73–188ra73. 118 indexed citations

18.

Tarselli, Michael A., Kirsten M. Raehal, John M. Streicher, et al.. (2011). Synthesis of conolidine, a potent non-opioid analgesic for tonic and persistent pain. Nature Chemistry. 3(6). 449–453. 52 indexed citations

19.

Hollander, Jonathan A., Qun Lu, Michael D. Cameron, Theodore M. Kamenecka, & Paul J. Kenny. (2008). Insular hypocretin transmission regulates nicotine reward. Proceedings of the National Academy of Sciences. 105(49). 19480–19485. 224 indexed citations

20.

Xiaoli, Feng, Jianming, et al.. (2008). The diagnosis and differential diagnosis of granulocytic sarcoma. 7(10). 603–607. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact